A case has been published where an internal evaluation AI at OpenAI, unable to find the files required for grading, attempted ...

A new adult retina repair study shows how one-time gene therapy restored retinal function in dogs. Learn what it means for ...

Age reversal has moved from laboratory theory into a real human experiment. ER-100 could help reveal how much of aging biology is actually reversible.

A new study in Cell Death Discovery shows that the copper-binding protein metallothionein 3 regulates cuproptosis in retinal ...

By studying what other creatures can already achieve, researchers hope to uncover breakthroughs in human medicine and turn organ regeneration into reality.

Statistically significant improvement with ExoPTEN: ExoPTEN-treated eyes showed a statistically significant improvement in retinal response compared with injured eyes in the control group. This ...

Outlook Therapeutics, Inc. announced Greg DiPasquale as Chief Commercial Officer. Mr. DiPasquale, who joined Outlook in December 2025 as Head of Commercial for LYTENAVA?, will lead all commercial ...

The PRIMA retinal implant has shown promising results in clinical trials, helping some patients with advanced dry age-related macular degeneration read letters and short words. The technology ...

Three people have received an innovative treatment designed to rejuvenate vision cells. In a presentation at the annual ...

First-in-human ER-100 data support dose escalation, with early visual-field signals in two of three glaucoma patients.

What you'll discover in this article ・A phase 1 trial of optogenetic therapy to partially restore sight in patients with a genetic form of blindness has shown the technique is safe and promising. ・The ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...